Sartorius Stedim Biotech announces integration of ambr 15 bioreactor with Nova BioProfile FLEX2

Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, has announced  the ambr® 15 automated micro bioreactor system combined with a Nova Biomedical (Nova) BioProfile® FLEX2 automated cell culture analyzer. This newly integrated system, which is a first from SSB and Nova’s successful collaboration, enables rapid at-line sample collection and analysis of massive quantities of key cell culture data.  

Sartorius Stedim Biotech’s ambr® 15 bioreactor system now can be combined with Nova’s BioProfile® FLEX2 automated cell culture analyzer.

SSB and Nova have collaborated to seamlessly integrate the software interface that controls the ambr® 15 workstation for automated parallel processing of 24 or 48 single-use bioreactors (10–15 mL working volume) with the cell culture analysis capabilities of the innovative BioProfile FLEX2. The combined system provides a unique tool to simultaneously run, sample and analyze a massive number of cell culture conditions during cell line and media development by Design of Experiments (DoE).

Combining the ambr® 15 and the BioProfile® FLEX2 enables fully integrated automatic sample transfer, analysis and automated feedback control in each single-use ambr® 15 bioreactor. This allows collection of enormous quantities of cell culture data, including total and viable cell density, viability, cell diameter, pH, PCO2, PO2, glucose, lactate, glutamine, glutamate, ammonium, Na+, K+, Ca++ and osmolality, which can be sampled and measured with a complete cycle time of just 6–7 minutes. The ambr® 15 software simultaneously acquires the BioProfile® FLEX2 data set and processes it, for example, by performing complex in-run calculations of how much feed volume to automatically add during a run. This saves time by significantly increasing the amount of consistent clone selection, media development and culture parameter data that a scientist can generate per run.  

“We have combined two highly innovative technologies. Our successful partnership with Nova has delivered complete at-line analytics capabilities for our ambr® 15 platform. Utilizing these integrated systems will support scientists to more easily run full QbD studies, without causing a sampling bottleneck or needing additional staff resources. The new system will optimize their process productivity, as well as the quality of their biologics,” stated Dr. Barney Zoro, ambr® Product Manager at Sartorius Stedim Biotech.  

“There is a significant demand for fully automated cell culture analysis of small-volume culture systems like the Sartorius ambr® micro bioreactor system,” said Matthew McRae, Biotechnology Sales Product Line Manager at Nova. “We’re excited to have worked with SSB on this integration program because our BioProfile FLEX2 with maintenance-free sensors provides rapid analysis of key cell culture tests using just 265 microliters of sample. As a result, this analyzer is a highly complementary addition to the ambr® 15 while maintaining the flexibility and modularity of the first-generation BioProfile FLEX analyzer.”

Posted in: Device / Technology News | Life Sciences News

Tags: , , , , , , ,

Comments

  1. Peter Jang Peter Jang Korea says:

    Vi-cell and Hi-res also can be integrated with Ambr15, but only Flex 2 can be utilitzed both ambr and other source of sample. It is huge advantage in point of investment of equipment and flexibility. And not only autosample function integration with flex 2 enable feedback control which all batch parameter can be controlled automatically.
    What a fantastic function it is!

  2. Dalsgaard Nicolaj Dalsgaard Nicolaj Denmark says:

    Does this also include integration of Ambr 250 with the Flex2?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post